ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.90
0.66%
US Tech 100
19,307.88
0.48%
S&P 500
5,482.87
0.09%
US Dollar vs CAD
1.37315
0.23%
Bitcoin
61,580.40
-0.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
06/24/20247:00AMGlobeNewswire Inc.IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual ConferenceNASDAQ:INABIN8bio Inc
06/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
06/13/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
06/13/20243:01PMGlobeNewswire Inc.IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100NASDAQ:INABIN8bio Inc
06/03/20247:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
06/03/20245:05AMGlobeNewswire Inc.IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:INABIN8bio Inc
05/24/20247:00AMGlobeNewswire Inc.IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024NASDAQ:INABIN8bio Inc
05/23/20244:00PMGlobeNewswire Inc.IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual MeetingNASDAQ:INABIN8bio Inc
05/14/20249:00AMGlobeNewswire Inc.IN8bio Announces Upcoming Presentation at 2024 European Hematology Association CongressNASDAQ:INABIN8bio Inc
05/13/20247:00AMGlobeNewswire Inc.IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024NASDAQ:INABIN8bio Inc
05/09/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
05/09/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
05/09/20243:00PMGlobeNewswire Inc.IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
05/07/20243:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
04/30/20245:05AMGlobeNewswire Inc.IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed GlioblastomaNASDAQ:INABIN8bio Inc
04/24/20247:00AMGlobeNewswire Inc.IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:INABIN8bio Inc
04/16/20243:05PMGlobeNewswire Inc.IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:INABIN8bio Inc
04/09/20243:30PMGlobeNewswire Inc.IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024NASDAQ:INABIN8bio Inc
03/14/20243:00PMGlobeNewswire Inc.IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:INABIN8bio Inc
03/05/20243:30PMGlobeNewswire Inc.IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024NASDAQ:INABIN8bio Inc
02/26/20247:00AMBusiness WireIN8bio to Present at Upcoming Investor ConferencesNASDAQ:INABIN8bio Inc
02/14/20247:00AMGlobeNewswire Inc.IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in ImmunologyNASDAQ:INABIN8bio Inc
02/08/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
02/08/20243:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
02/08/20243:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
02/08/20243:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
02/08/20243:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

BIT
NSCITA1G0D01
European Financial Stabi...
TG
A30VQ0
DBK
BIT
P21VA5
NLBNPIT21VA5 20241028 100
BOV
CTKA4F
KARSTEN PN
BIT
P1X112
NLBNPIT1X112 20240918 38...
BIT
US10C
Amundi US Treasury Bond ...
BIT
P1ZP46
NLBNPIT1ZP46 20240620 4900
BOV
BRFS3M
BRF S/A ON
BIT
UC7WKF
Unicredit Bank
DOWI
DWCBSC
DJ US Basic Resources To...
NASDAQ
NAVG
Navigators
USOTC
CNLLF
Central China Real Estate (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved